Blood Research

Cited by CrossRef (26)

  1. Edon J. Rabinowitz, Amy Ouyang, Dustin R. Armstrong, Michael Wallendorf, Ahmed S. Said. Poor Reliability of Common Measures of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation. 2022;68:850
    https://doi.org/10.1097/MAT.0000000000001582
  2. Vanessa Carle, Yuteng Wu, Rakesh Mukherjee, Xu-Dong Kong, Chloé Rogg, Quentin Laurent, Enza Cecere, Camille Villequey, Madhuree S. Konakalla, Tamara Maric, Christina Lamers, Cristina Díaz-Perlas, Kaycie Butler, Junko Goto, Bernd Stegmayr, Christian Heinis. Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation. J. Med. Chem. 2021;64:6802
    https://doi.org/10.1021/acs.jmedchem.1c00056
  3. Takeshi Matsumoto, Hideo Wada, Naoki Fujimoto, Junki Toyoda, Yasunori Abe, Kohshi Ohishi, Yoshiki Yamashita, Makoto Ikejiri, Kei Hasegawa, Kei Suzuki, Hiroshi Imai, Kaname Nakatani, Naoyuki Katayama. An Evaluation of the Activated Partial Thromboplastin Time Waveform. Clin Appl Thromb Hemost 2018;24:764
    https://doi.org/10.1177/1076029617724230
  4. Vijisha Thalappil, Jeyanthi Anand, Anish Keepanasseril, Rakhee Kar. Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy. Indian J Hematol Blood Transfus 2023
    https://doi.org/10.1007/s12288-023-01718-2
  5. Ladan Panahi, George Udeani, Michael Horseman, Jaye Weston, Nephy Samuel, Merlyn Joseph, Andrea Mora, Daniela Bazan, Pooja Patel. New Knowledge about Pulmonary Thromoboembolism. 2023.
    https://doi.org/10.5772/intechopen.100471
  6. Hideo Wada, Katsuya Shiraki, Takeshi Matsumoto, Kohshi Ohishi, Hideto Shimpo, Yumi Sakano, Hiroko Nishii, Motomu Shimaoka. The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay. Clin Appl Thromb Hemost 2021;27:107602962097691
    https://doi.org/10.1177/1076029620976913
  7. Sheldon Goldstein, Jazmin Juarez, Agathe Streiff. Erroneous Activated Coagulation Time During Atrial Flutter Ablation. Case Reports in Anesthesiology 2020;2020:1
    https://doi.org/10.1155/2020/3842051
  8. Jean Amiral, Cédric Amiral, Claire Dunois. Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity. Biomedicines 2021;9:700
    https://doi.org/10.3390/biomedicines9060700
  9. Razvan I. Radu, Tuvia Ben Gal, Magdy Abdelhamid, Elena‐Laura Antohi, Marianna Adamo, Andrew P. Ambrosy, Oliviana Geavlete, Yuri Lopatin, Alexander Lyon, Oscar Miro, Marco Metra, John Parissis, Sean P. Collins, Stefan D. Anker, Ovidiu Chioncel. Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature. ESC Heart Failure 2021;8:4717
    https://doi.org/10.1002/ehf2.13643
  10. Asha G. Nair, Olubunmi O. Oladunjoye, Cameron C. Trenor, Meena LaRonde, Sarah J. van den Bosch, Lynn A. Sleeper, Christina VanderPluym, Sitaram M. Emani, John N. Kheir. An anticoagulation protocol for use after congenital cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery 2018;156:343
    https://doi.org/10.1016/j.jtcvs.2018.02.106
  11. James W. Schurr, Anne-Marie Muske, Craig A. Stevens, Sarah E. Culbreth, Katelyn W. Sylvester, Jean M. Connors. Derivation and Validation of Age- and Body Mass Index-Adjusted Weight-Based Unfractionated Heparin Dosing. Clin Appl Thromb Hemost 2019;25:107602961983348
    https://doi.org/10.1177/1076029619833480
  12. Kenji Miyazawa, Aaron L. Fogelson, Karin Leiderman. Inhibition of platelet-surface-bound proteins during coagulation under flow II: Antithrombin and heparin. Biophysical Journal 2023;122:230
    https://doi.org/10.1016/j.bpj.2022.10.038
  13. Kei Suzuki, Hideo Wada, Takeshi Matsumoto, Makoto Ikejiri, Kohshi Ohishi, Yoshiki Yamashita, Hiroshi Imai, Toshiaki Iba, Naoyuki Katayama. Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk. Thrombosis J 2019;17
    https://doi.org/10.1186/s12959-019-0201-0
  14. Yongzhe Hong, Sola Mansour, Ghazi Alotaibi, Cynthia Wu, Michael Sean McMurtry. Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials. Critical Reviews in Oncology/Hematology 2018;125:12
    https://doi.org/10.1016/j.critrevonc.2018.02.010
  15. Brett J. Wakefield, Nakul Kumar, Shiva Sale, Balaram Anandamurthy. Advances in Cardiovascular Technology. 2018.
    https://doi.org/10.1016/B978-0-12-816861-5.00036-8
  16. Haruna Katayama, Takeshi Matsumoto, Hideo Wada, Naoki Fujimoto, Junki Toyoda, Yasunori Abe, Kohshi Ohishi, Yoshiki Yamashita, Makoto Ikejiri, Koji Habe, Naoyuki Katayama. An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform. Clin Appl Thromb Hemost 2018;24:1170
    https://doi.org/10.1177/1076029618757344
  17. Simon Craige, Annukka Jouppila, Bob Humphries, Riitta Lassila. Safety and Functional Pharmacokinetic Profile of APAC, a Novel Intravascular Antiplatelet and Anticoagulant. 2021;78:453
    https://doi.org/10.1097/FJC.0000000000001080
  18. Hideo Wada, Takeshi Matsumoto, Kohshi Ohishi, Katsuya Shiraki, Motomu Shimaoka. Update on the Clot Waveform Analysis. Clin Appl Thromb Hemost 2020;26:107602962091202
    https://doi.org/10.1177/1076029620912027
  19. Ladan Panahi, George Udeani, Michael Horseman, Jaye Weston, Nephy Samuel, Merlyn Joseph, Andrea Mora, Daniela Bazan. Review of Medical Therapies for the Management of Pulmonary Embolism. Medicina 2021;57:110
    https://doi.org/10.3390/medicina57020110
  20. Hideo Wada, Katsuya Shiraki, Takeshi Matsumoto, Kei Suzuki, Yoshiki Yamashita, Isao Tawara, Hideto Shimpo, Motomu Shimaoka. A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab. JCM 2022;11:6142
    https://doi.org/10.3390/jcm11206142
  21. Kevin McLaughlin, Jessica Rimsans, Katelyn W. Sylvester, John Fanikos, David M. Dorfman, Patricia Senna, Jean M. Connors, Samuel Z. Goldhaber. Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy. Clin Appl Thromb Hemost 2019;25:107602961987603
    https://doi.org/10.1177/1076029619876030
  22. Galit H. Frydman, Barry M. Berger, Vadim Kostousov, Karen Bruzdovski, Dimitrios P. Papageorgiou, Amir Navaei, Shiu-Ki Rocky Hui, Jun Teruya. Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation. 2022;4:e0776
    https://doi.org/10.1097/CCE.0000000000000776
  23. Caitlin E. Kulig, Kendra J. Schomer, Hugh B. Black, William E. Dager. Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients. 2021;67:411
    https://doi.org/10.1097/MAT.0000000000001246
  24. M. Hasegawa, H. Wada, S. Tone, T. Yamaguchi, H. Wakabayashi, M. Ikejiri, M. Watanabe, N. Fujimoto, T. Matsumoto, K. Ohishi, Y. Yamashita, N. Katayama, A. Sudo. Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform. Int J Lab Hematology 2018;40:49
    https://doi.org/10.1111/ijlh.12727
  25. Frantzeska Frantzeskaki, Dimitrios Konstantonis, Michail Rizos, Vasileios Kitsinelis, Georgios Skyllas, Ioannis Renieris, Maria Doumani, Vasileios Kolias, Eirini Kefalidi, Dimitrios Angouras, Argyrios Tsantes, Iraklis Tsangaris. Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics 2023;13:3496
    https://doi.org/10.3390/diagnostics13233496
  26. Matthew Lawlor, Aakriti Gupta, Lauren S. Ranard, Mahesh V. Madhavan, Jianhua Li, Andrew Eisenberger, Sahil A. Parikh, Sanjum S. Sethi, Amirali Masoumi. Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy. Thrombosis Research 2021;198:79
    https://doi.org/10.1016/j.thromres.2020.11.030
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd